(1888PressRelease)
March 21, 2008 - The Atlantic Biotherapies Biocluster, which is based in western France, will sponsor the BIO-Europe Spring conference, which will be held in Madrid from 7 to 9 April 2008. Six of the cluster’s members will be exhibiting together at Booth 36 and will also be meeting their Madrid biocluster counterparts during the trade show.
Atlantic Biotherapies is a High-Level Sponsor of BIO-Europe Spring. At the event, its stand will bring together six cutting-edge companies. Algenics is a producer of recombinant proteins from microalgae for use in therapeutic, cosmetic or nutraceutical applications, while Chelatec specialises in the radioactive marking of products used for therapeutic or diagnostic purposes, and for preclinical in-vitro and in-vivo evaluations. For its part, Clean Cells, a specialist in biological safety laboratories (level 2 and 3) for rapid inspections and regulatory validation of production processes and biological products, was an award winner at the Fondation Aventis – Institut de France 2000 event.
In-Cell-Art specialises in the safe transport of active principles (DNA, siRNA, proteins) right to the heart of cells, while Porsolt & Partners Pharmacology is a CRO specialising in animal pharmacology that provides evaluations of therapeutic efficacy and of drug safety for major vital systems. Finally, Vivalis SA is a specialist in using avian stem cell lines to produce viral vaccines and recombinant proteins, as well as in the customised production of viral vaccines and recombinant proteins that are compliant with GMP/BPF standards.
Atlantic Biotherapies brings together 44 companies, 28 laboratories, two university hospital centres, two cancer-fighting centres, two universities, one veterinary school, and various other platforms and institutes. Its areas of expertise are cellular and genetic therapy, immuno-intervention and immuno-technology, biomaterials (molecular, cellular and tissue engineering) and radiopharmaceuticals.
Atlantic Biotherapies’ European Biocluster partners are Aresa (Wallonia), BioAlps (Switzerland), Heidelberg Technology Park (Germany), Leiden Life Meets Science (Netherlands), Madrid Biocluster (Spain), Medcoast Scandinavia (Norway/Sweden), Milan Biocluster (Italy), Tartu Science Park (Estonia) and Wales Gene Park (United Kingdom).
About Atlantic Biotherapies
The Atlantic Biotherapies cluster, which is headquartered in Nantes (in western France), harnesses the skills and infrastructures of its members to discover, develop and produce targeted treatments that ensure customised medical therapies. Since its creation in 2005, Atlantic Biotherapies has been instrumental in establishing 117 R&D consortiums.
Atlantic Biotherapies will take part in the following upcoming events: BIO-Europe Spring in Madrid (Spain) from 7 to 9 April 2008; BioBangalore in Bangalore (India) from 24 to 26 April 2008; BioMed Israel in Tel Aviv (Israel) from 27 to 29 May 2008; Bio San Diego in San Diego (USA) from 17 to 20 June 2008 (seven firms will be present at Booth 2601 on the French Pavilion); and Eurobio Paris in Paris (France) from 6 to 9 October 2008 (12 firms will be present).
For further information about the companies taking part in the BIO-Europe Spring event, please go to: www.chelatec.fr, www.clean-cells.fr, www.incellart.com, www.porsolt.com and www.vivalis.com.
For further information, please go to: www.atlantic-biotherapies.com
